← Back to Search

Observational (survey) for Brain Tumor

N/A
Waitlist Available
Led By Ashley Aaroe, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights

Summary

This study investigates how seizures can vary over time with changes in low grade gliomas and its treatments. This study may help doctors find symptoms or triggers of seizures earlier than normal, and ultimately earlier care or treatment for seizures.

Eligible Conditions
  • Brain Tumor
  • Low Grade Glioma
  • Epilepsy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Seizures
Status of tumor
Secondary outcome measures
Overall survival (OS)
Patient data collection
Progression-free survival (PFS)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Observational (survey)Experimental Treatment1 Intervention
Patients complete a seizure assessment survey over 5 minutes at each clinic visit.

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,039 Previous Clinical Trials
1,799,601 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
41,002,900 Total Patients Enrolled
Ashley Aaroe, MDPrincipal InvestigatorM.D. Anderson Cancer Center
~23 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top